Suggested Topics within your search.
Suggested Topics within your search.
human
13
Humans
11
apoptosis
8
Oncology
7
Article
6
antineoplastic agent
6
chemistry
6
Biology, life sciences
5
Neoplasms
5
cisplatin
5
metabolism
5
neoplasm
5
Anticancer
4
Antineoplastic Agents
4
anticancer
4
cancer chemotherapy
4
cancer therapy
4
colorectal cancer
4
controlled study
4
cytotoxicity
4
doxorubicin
4
drug delivery system
4
fluorouracil
4
in vitro study
4
unclassified drug
4
Animals
3
Antimicrobial
3
Chemotherapy
3
Drug Delivery Systems
3
Magnetic nanoparticles
3
-
5941“... components or focus on identifying targeted drugs for use in cancer therapy. Despite extensive...”
Get full text
Article -
5942by Bojan Ljepoja, Jonathan García-Roman, Ann-Katrin Sommer, Thomas Fröhlich, Georg J. Arnold, Ernst Wagner, Andreas Roidl“...Abstract Loss of miR-200c is correlated to advanced cancer-subtypes due to increased EMT...”
Published 2018-05-01
Get full text
Article -
5943“... in regenerative medicine. Radiotherapy is the most often used method in the treatment of cancer. In the future...”
Get full text
Article -
5944by Camila Ribeiro de Arruda Monteiro, Jean Henri Maselli Schoueri, Debora Terra Cardial, Lívia de Castro Linhares, Karine Corcione Turke, Lia Vineyard Steuer, Levy Werneck de Almeida Menezes, Igor Luiz Argani, Claudia Sette, Daniel de Iracema Gomes Cubero, Auro del Giglio“.... It is of particular importance in cancer patients since they are often in use of polypharmacy, related to interactions...”
Get full text
Article -
5945by Yang Yang, Liang Hu, Chaoyu Wang, Xing Yang, Ling Song, Chunyi Jiang, Yan Li, Tianxi Li, Wen-Tao Liu, Jifeng Feng“...Chemotherapy induced peripheral neuropathy (CIPN) is a serious adverse effect of chemotherapeutics...”
Published 2019-01-01
Get full text
Article -
5946by Jerry D. Monroe, Satya A. Moolani, Elvin N. Irihamye, Katheryn E. Lett, Michael D. Hebert, Yann Gibert, Michael E. Smith“... to traditional platinum-based chemotherapeutics, e.g., cisplatin. Here, we treated A549 non-small cell lung...”
Published 2021-05-01
Get full text
Article -
5947by Stuart J. Gallagher, John F. Thompson, James Indsto, Lyndee L. Scurr, Margaret Lett, Bo-Fu Gao, Ruth Dunleavey, Graham J. Mann, Richard F. Kefford, Helen Rizos“... response rates to systemic chemotherapeutics. Patients who undergo isolated limb infusion (ILI...”
Published 2008-11-01
Get full text
Article -
5948by Prieske, Silvia“... to normal cells. Consequently, these findings have triggered the design of novel TRAIL-based cancer...”
Published 2012
Get full text
-
5949by Skye Hsin-Hsien Yeh, Ming Hsien Lin, I. I. Leo Garcia Flores, Uday Mukhopadhyay, Danial Young, Kazuma Ogawa, Jeong-Hwan Jeong, William Tong, Juri G. Gelovani, Nobuyoshi Fukumitsu“... as chemosensitizers for platinum-based chemotherapeutics has recently been proven in many types and stages of cancer...”
Published 2021-01-01
Get full text
Article -
5950by Rachael E Hawtin, David E Stockett, Jo Ann W Byl, Robert S McDowell, Tan Nguyen, Michelle R Arkin, Andrew Conroy, Wenjin Yang, Neil Osheroff, Judith A Fox“... derivative, a chemical scaffold not used previously for cancer treatment. Voreloxin is completing Phase 2...”
Published 2010-04-01
Get full text
Article -
5951by Małgorzata Milczarek, Lidia Mielczarek, Katarzyna Lubelska, Aleksandra Dąbrowska, Zdzisław Chilmonczyk, Dariusz Matosiuk, Katarzyna Wiktorska“... anticancer activity in both in vivo and in vitro studies. Recent attempts to expand their use in cancer...”
Published 2018-11-01
Get full text
Article -
5952“... been touted as a specific target for antitumor chemotherapeutics. In the path, our laboratory...”
Get full text
Others -
5953by Hyo Jeong Kang, Hyang Sook Seol, Sang Eun Lee, Young-Ah Suh, Jihun Kim, Se Jin Jang, Eunsil Yu“...Background Development of chemotherapeutics for the treatment of advanced hepatocellular carcinoma...”
Published 2019-03-01
Get full text
Article -
5954
-
5955by Stefan K. Zöllner, James F. Amatruda, Sebastian Bauer, Stéphane Collaud, Enrique de Álava, Steven G. DuBois, Jendrik Hardes, Wolfgang Hartmann, Heinrich Kovar, Markus Metzler, David S. Shulman, Arne Streitbürger, Beate Timmermann, Jeffrey A. Toretsky, Yasmin Uhlenbruch, Volker Vieth, Thomas G. P. Grünewald, Uta Dirksen“...Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime example...”
Published 2021-04-01
Get full text
Article -
5956by Pengfei Zhang, Jing Liu, Bohui Xiong, Cong Zhang, Beining Kang, Yishan Gao, Zengkuan Li, Wei Ge, Shunfeng Cheng, Yanan Hao, Wei Shen, Shuai Yu, Liang Chen, Xiangfang Tang, Yong Zhao, Hongfu Zhang“...Abstract Background The increasing incidence of cancer and intestinal mucositis induced...”
Published 2020-07-01
Get full text
Article -
5957“... to neuropathy for example, alterations in neurite morphology in response to chemotherapeutics. Our study...”
Get full text
Article -
5958by Fazilath Uzma, Chakrabhavi D. Mohan, Abeer Hashem, Narasimha M. Konappa, Shobith Rangappa, Praveen V. Kamath, Bhim P. Singh, Venkataramana Mudili, Vijai K. Gupta, Chandra N. Siddaiah, Srinivas Chowdappa, Abdulaziz A. Alqarawi, Elsayed F. Abd_Allah“...Cancer is a major cause of death worldwide, with an increasing number of cases being reported...”
Published 2018-04-01
Get full text
Article -
5959by Debajit Bhowmick, Kaushik Bhar, Sanjaya K. Mallick, Subhadip Das, Nabanita Chatterjee, Tuhin Subhra Sarkar, Rajarshi Chakrabarti, Krishna Das Saha, Anirban Siddhanta“...Melanoma is one of the most aggressive forms of cancer, usually resistant to standard...”
Published 2016-01-01
Get full text
Article -
5960by Vinaya Phatak, Yannick von Grabowiecki, Justyna Janus, Leah Officer, Caron Behan, Lydia Aschauer, Lucia Pinon, Hannah Mackay, Sara Zanivan, Jim C. Norman, Michael Kelly, John Le Quesne, Patricia A. J. Muller“...Abstract TP53 is the most frequently mutated gene in cancers. Mutations lead to loss of p53...”
Published 2021-02-01
Get full text
Article